Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Raltegravir may cause hair loss in some patients.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Indinavir and ritonavir therapy can cause reversible hair loss.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

34% of patients on hepatitis C treatment had reversible skin issues.

The medication lopinavir-ritonavir may cause severe hair loss.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Apremilast showed mixed results for treating severe alopecia areata.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Apremilast did not work for treating severe alopecia areata.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Apremilast improved symptoms in patients with severe skin conditions.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Apremilast may be a promising long-term treatment for hidradenitis suppurativa.

Alopecia universalis can be an early sign of HIV.